Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (631) 631
Magazine Article (40) 40
Publication (14) 14
Trade Publication Article (11) 11
Book Chapter (8) 8
Book / eBook (5) 5
Book Review (4) 4
Conference Proceeding (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (317) 317
life sciences & biomedicine (306) 306
humans (290) 290
male (272) 272
middle aged (174) 174
prostate cancer (171) 171
urology & nephrology (169) 169
aged (154) 154
biological and medical sciences (152) 152
medical sciences (150) 150
urology (128) 128
nephrology. urinary tract diseases (105) 105
tumors (93) 93
urinary tract. prostate gland (92) 92
abridged index medicus (88) 88
cancer (86) 86
tumors of the urinary system (85) 85
oncology (78) 78
prostate-specific antigen - blood (77) 77
risk factors (77) 77
prostate (74) 74
prostatic neoplasms - pathology (72) 72
prostatic neoplasms - diagnosis (65) 65
prostate-specific antigen (61) 61
female (60) 60
biopsy (56) 56
gynecology. andrology. obstetrics (55) 55
research (54) 54
diagnosis (53) 53
male genital diseases (52) 52
prostatic neoplasms - blood (47) 47
adult (42) 42
dutasteride (38) 38
prostatic neoplasms (38) 38
prostatic neoplasms - genetics (35) 35
health aspects (34) 34
prostate - pathology (34) 34
prostatic neoplasms - epidemiology (34) 34
surgery (34) 34
analysis (33) 33
case-control studies (32) 32
medicin och hälsovetenskap (32) 32
prostatic neoplasms - prevention & control (32) 32
care and treatment (31) 31
prevention (31) 31
aged, 80 and over (30) 30
oncology, experimental (30) 30
prostatectomy (29) 29
azasteroids - therapeutic use (28) 28
medical screening (28) 28
mortality (28) 28
follow-up studies (27) 27
prognosis (27) 27
prospective studies (27) 27
prostatic neoplasms - mortality (27) 27
usage (27) 27
general & internal medicine (26) 26
genetic predisposition to disease (26) 26
medicine, general & internal (26) 26
predictive value of tests (26) 26
men (25) 25
double-blind method (24) 24
mass screening (24) 24
polymorphism, single nucleotide (24) 24
5-alpha reductase inhibitors - therapeutic use (23) 23
genetics & heredity (23) 23
neoplasm staging (22) 22
treatment outcome (22) 22
medical research (21) 21
retrospective studies (21) 21
clinical trials (20) 20
genome-wide association study (20) 20
prostatic neoplasms - surgery (20) 20
randomized controlled trials as topic (20) 20
risk (19) 19
cohort studies (18) 18
epidemiology (18) 18
incidence (18) 18
prostatic hyperplasia - drug therapy (18) 18
prostatic neoplasms - drug therapy (18) 18
risk assessment (18) 18
neoplasm grading (17) 17
pharmacology. drug treatments (17) 17
prostatic neoplasms - therapy (17) 17
surveys and questionnaires (17) 17
genotype (16) 16
magnetic resonance imaging (16) 16
medical colleges (16) 16
public, environmental & occupational health (16) 16
united states - epidemiology (16) 16
antigens (15) 15
biomarkers, tumor - blood (15) 15
early detection of cancer (15) 15
hypertrophy (15) 15
finasteride - therapeutic use (14) 14
interstitial cystitis (14) 14
medicine, experimental (14) 14
ovarian cancer (14) 14
studies (14) 14
time factors (14) 14
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Dutasteride: A Viewpoint by Gerald L. Andriole
by Andriole G.L
Drugs & aging, ISSN 1170-229X, 2003, Volume 20, Issue 12, pp. 917 - 918
Benign prostatic hyperplasia, treatment | Dutasteride, general | 5 alpha reductase inhibitors, general | Adis Drug Profiles | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Geriatrics/Gerontology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Prevention and early detection of prostate cancer
by Cuzick, Jack, Prof and Thorat, Mangesh A, MBBS and Andriole, Gerald, Prof and Brawley, Otis W, Prof and Brown, Powel H, Prof and Culig, Zoran, MD and Eeles, Rosalind A, Prof and Ford, Leslie G, MD and Hamdy, Freddie C, Prof and Holmberg, Lars, Prof and Ilic, Dragan, PhD and Key, Timothy J, Prof and Vecchia, Carlo La, Prof and Lilja, Hans, Prof and Marberger, Michael, Prof and Meyskens, Frank L, Prof and Minasian, Lori M, MD and Parker, Chris, MD and Parnes, Howard L, MD and Perner, Sven, Prof and Rittenhouse, Harry, PhD and Schalken, Jack, Prof and Schmid, Hans-Peter, Prof and Schmitz-Dräger, Bernd J, Prof and Schröder, Fritz H, Prof and Stenzl, Arnulf, Prof and Tombal, Bertrand, Prof and Wilt, Timothy J, Prof and Wolk, Alicja, Prof
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. e484 - e492
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Immunohistochemistry | Life Style | Prognosis | Age Factors | Early Detection of Cancer - methods | Risk Reduction Behavior | Biomarkers, Tumor - analysis | Humans | Middle Aged | Risk Factors | Male | Prostatic Neoplasms - diagnosis | Evidence-Based Medicine | Prostate-Specific Antigen - blood | Prostatic Neoplasms - therapy | Neoplasm Invasiveness - pathology | Primary Prevention - methods | Aged, 80 and over | Aged | Biopsy, Needle | Prostatic Neoplasms - prevention & control | Prevention | Diagnosis | Prostate cancer | Cancer | Index Medicus | prostate cancer | risk factors | screening | prevention | PSA | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
by Schumacher, Fredrick R and Al Olama, Ali Amin and Berndt, Sonja I and Benlloch, Sara and Ahmed, Mahbubl and Saunders, Edward J and Dadaev, Tokhir and Leongamornlert, Daniel and Anokian, Ezequiel and Cieza-Borrella, Clara and Goh, Chee and Brook, Mark N and Sheng, Xin and Fachal, Laura and Dennis, Joe and Tyrer, Jonathan and Muir, Kenneth and Lophatananon, Artitaya and Stevens, Victoria L and Gapstur, Susan M and Carter, Brian D and Tangen, Catherine M and Goodman, Phyllis J and Thompson, Ian M and Batra, Jyotsna and Chambers, Suzanne and Moya, Leire and Clements, Judith and Horvath, Lisa and Tilley, Wayne and Risbridger, Gail P and Gronberg, Henrik and Aly, Markus and Nordström, Tobias and Pharoah, Paul and Pashayan, Nora and Schleutker, Johanna and Tammela, Teuvo L. J and Sipeky, Csilla and Auvinen, Anssi and Albanes, Demetrius and Weinstein, Stephanie and Wolk, Alicja and Håkansson, Niclas and West, Catharine M. L and Dunning, Alison M and Burnet, Neil and Mucci, Lorelei A and Giovannucci, Edward and Andriole, Gerald L and Cussenot, Olivier and Cancel-Tassin, Géraldine and Koutros, Stella and Beane Freeman, Laura E and Sorensen, Karina Dalsgaard and Orntoft, Torben Falck and Borre, Michael and Maehle, Lovise and Grindedal, Eli Marie and Neal, David E and Donovan, Jenny L and Hamdy, Freddie C and Martin, Richard M and Travis, Ruth C and Key, Tim J and Hamilton, Robert J and Fleshner, Neil E and Finelli, Antonio and Ingles, Sue Ann and Stern, Mariana C and Rosenstein, Barry S and Kerns, Sarah L and Ostrer, Harry and Lu, Yong-Jie and Zhang, Hong-Wei and Feng, Ninghan and Mao, Xueying and Guo, Xin and Wang, Guomin and Sun, Zan and Giles, Graham G and Southey, Melissa C and MacInnis, Robert J and Fitzgerald, Liesel M and Kibel, Adam S and Drake, Bettina F and Vega, Ana and Gómez-Caamaño, Antonio and Szulkin, Robert and Eklund, Martin and Kogevinas, Manolis and Llorca, Javier and Castaño-Vinyals, Gemma and Penney, Kathryn L and Stampfer, Meir and Park, Jong Y and Sellers, Thomas A and Lin, Hui-Yi and Stanford, Janet L and Cybulski, Cezary and ... and Profile Study and Canary PASS Investigators and Canc Prostate Sweden CAPS and IMPACT Study and Prostate Canc Genome-wide As and APCB and Breast Prostate Canc Cohort Consor and PRACTICAL Prostate Canc As and Genetic Assoc Mech Oncology GAME and Breast and Prostate Cancer Cohort Consortium (BPC3) and Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS) and Australian Prostate Cancer BioResource (APCB) and Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium and Cancer of the Prostate in Sweden (CAPS) and PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium and The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium and The IMPACT Study and The Profile Study and The Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium
Nature genetics, ISSN 1061-4036, 07/2018, Volume 50, Issue 7, pp. 928 - 936
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Genetic Predisposition to Disease | Prostatic Neoplasms - genetics | Humans | Genotype | Male | Risk | Polymorphism, Single Nucleotide | Genetic Loci | Genome-Wide Association Study - methods | Case-Control Studies | Case studies | Genome-wide association studies | Usage | Men | Genetic aspects | Health aspects | Prostate cancer | Risk factors | Genealogy | Data processing | Mapping | Genomes | Biology | Family medical history | Loci | Meta-analysis | Confidence intervals | Consortia | Signal transduction | Software | Gene mapping | Health risk assessment | Prostate | Genotypes | Cancer | Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia
by McConnell, John D and Roehrborn, Claus G and Bautista, Oliver M and Andriole, Gerald L and Dixon, Christopher M and Kusek, John W and Lepor, Herbert and McVary, Kevin T and Nyberg, Leroy M and Clarke, Harry S and Crawford, E. David and Diokno, Ananias and Foley, John P and Foster, Harris E and Jacobs, Stephen C and Kaplan, Steven A and Kreder, Karl J and Lieber, Michael M and Lucia, M. Scott and Miller, Gary J and Menon, Mani and Milam, Douglas F and Ramsdell, Joe W and Schenkman, Noah S and Slawin, Kevin M and Smith, Joseph A and MTOPS Res Grp and Medical Therapy of Prostatic Symptoms (MTOPS) Research Group
The New England journal of medicine, ISSN 0028-4793, 12/2003, Volume 349, Issue 25, pp. 2387 - 2398
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Enzyme Inhibitors - adverse effects | Severity of Illness Index | Double-Blind Method | Humans | Middle Aged | 5-alpha Reductase Inhibitors | Adrenergic alpha-Antagonists - therapeutic use | Male | Prostatic Hyperplasia - classification | Enzyme Inhibitors - therapeutic use | Disease Progression | Prostatic Hyperplasia - surgery | Finasteride - adverse effects | Adrenergic alpha-Antagonists - adverse effects | Analysis of Variance | Doxazosin - therapeutic use | Finasteride - therapeutic use | Doxazosin - adverse effects | Drug Therapy, Combination | Prostatic Hyperplasia - drug therapy | Evaluation | Doxazosin | Finasteride | Drug therapy | Prostate | Hypertrophy | Clinical trials | Prostate cancer | Urogenital system | Older people | Men | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text What is the best PET target for early biochemical recurrence of prostate cancer?
by Andriole, Gerald L
The lancet oncology, ISSN 1470-2045, 11/2019, Volume 20, Issue 11, pp. e608 - e608
Life Sciences & Biomedicine | Oncology | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Extended mortality results for prostate cancer screening in the PLCO trial with median follow‐up of 15 years
by Pinsky, Paul F and Prorok, Philip C and Yu, Kelly and Kramer, Barnett S and Black, Amanda and Gohagan, John K and Crawford, E. David and Grubb, Robert L and Andriole, Gerald L
Cancer, ISSN 0008-543X, 02/2017, Volume 123, Issue 4, pp. 592 - 599
prostate‐specific antigen (PSA) | digital rectal examination (DRE) | prostate cancer | screening | randomized trial | prostate-specific antigen (PSA) | Life Sciences & Biomedicine | Oncology | Science & Technology | Prostatic Neoplasms - pathology | American Cancer Society | Follow-Up Studies | Early Detection of Cancer | Humans | Middle Aged | Prostatic Neoplasms - blood | Male | Aged | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Care and treatment | Patient outcomes | Analysis | Clinical trials | Outcome and process assessment (Health Care) | Diagnosis | Research | Prostate cancer | Intervention | Ovarian carcinoma | Prostate-specific antigen | Mortality | Lung cancer | Medical screening | Ovarian cancer | Confidence intervals | Screening | Randomization | Rectum | Men | Death | Fatalities | Health risk assessment | Prostate | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Serum Prostate-Specific Antigen Hemodilution Among Obese Men Undergoing Screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
by Robert L. Grubb III and Amanda Black and Grant Izmirlian and Thomas P. Hickey and Paul F. Pinsky and Jerome E. Mabie and Thomas L. Riley and Lawrence R. Ragard and Philip C. Prorok and Christine D. Berg and E. David Crawford and Timothy R. Church and Gerald L. Andriole, Jr and PLCO Project Team and for the PLCO Project Team
Cancer epidemiology, biomarkers & prevention, ISSN 1055-9965, 03/2009, Volume 18, Issue 3, pp. 748 - 751
cancer screening | hemodilution | body mass index | obesity | prostate-specific antigen | Oncology | Public, Environmental & Occupational Health | Life Sciences & Biomedicine | Science & Technology | Obesity | Biological and medical sciences | Metabolic diseases | Medical sciences | Tumors | Body Mass Index | Obesity - complications | Humans | Middle Aged | Male | Chi-Square Distribution | Obesity - blood | Prostate-Specific Antigen - blood | Mass Screening | Analysis of Variance | Prostatic Neoplasms - blood | Hemodilution | Surveys and Questionnaires | Aged | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Mortality Results from a Randomized Prostate-Cancer Screening Trial
by Andriole, Gerald L and Crawford, E. David and Grubb, Robert L and Buys, Saundra S and Chia, David and Church, Timothy R and Fouad, Mona N and Gelmann, Edward P and Kvale, Paul A and Reding, Douglas J and Weissfeld, Joel L and Yokochi, Lance A and O'Brien, Barbara and Clapp, Jonathan D and Rathmell, Joshua M and Riley, Thomas L and Hayes, Richard B and Kramer, Barnett S and Izmirlian, Grant and Miller, Anthony B and Pinsky, Paul F and Prorok, Philip C and Gohagan, John K and Berg, Christine D and PLCO Project Team
The New England journal of medicine, ISSN 0028-4793, 03/2009, Volume 360, Issue 13, pp. 1310 - 1319
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Biological and medical sciences | General aspects | Medical sciences | Epidemiology | United States - epidemiology | Follow-Up Studies | Humans | Middle Aged | Male | Prostatic Neoplasms - diagnosis | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Incidence | Prostatic Neoplasms - epidemiology | Mass Screening - adverse effects | Digital Rectal Examination - adverse effects | Aged | Patient Compliance | Medical screening | Prostate cancer | Mortality | Age | Men | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Comorbidity and Mortality Results From a Randomized Prostate Cancer Screening Trial
by E. David Crawford and Robert Grubb III and Amanda Black and Gerald L. Andriole Jr and Ming-Hui Chen and Grant Izmirlian and Christine D. Berg and Anthony V. D'Amico
Journal of clinical oncology, ISSN 0732-183X, 02/2011, Volume 29, Issue 4, pp. 355 - 361
Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Tumors | Predictive Value of Tests | Prognosis | Risk Assessment | Comorbidity | United States | Humans | Middle Aged | Risk Factors | Male | Unnecessary Procedures | Prostatic Neoplasms - diagnosis | Chi-Square Distribution | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Prostatic Neoplasms - therapy | Mass Screening | Time Factors | Survival Analysis | Surveys and Questionnaires | Aged | Index Medicus | Original Reports | Guc3 | Guc4 | Guc1 | Guc2
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights